Hepatitis B and C Viruses and Their Interaction in the Origin of Hepatocellular Carcinoma
JAMAPublished 17 April 1991
E. Kaklamani
Citations200
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Serum taken from patients in a case-control study in Athens, Greece, was used to examine the interactive roles of hepatitis B virus (HBV) and hepatitis C virus (HCV) in the origin of hepatocellular carcinoma, indicating that HCV infection has an interactive role in theorigin of HCC.
Abstract
Serum taken from patients in a case-control study in Athens, Greece, was used to examine the interactive roles of hepatitis B virus (HBV) and hepatitis C virus (HCV) in the origin of hepatocellular carcinoma (HCC). An enzyme immunoassay for anti-HCV was used to test serum taken from 185 cases with HCC, 35 cases with metastatic liver cancer (MLC), and 432 hospital controls. Weakly positive anti-HCV results were more strongly related to MLC than to HCC, implying that these anti-HCV results are false positive. By contrast, strongly positive anti-HCV results were significantly related to HCC (relative risk [RR], 6.3), whereas no significant association was evident for MLC (RR, 0.6). The association of anti-HCV with HCC was substantially higher among subjects whose radioimmunoassay was positive for hepatitis B surface antigen (RR, 20.0) than among those whose radioimmunoassay was negative for this marker (RR, 4.8). These findings indicate that HCV infection has an interactive role in the origin of HCC.
Keywords
Medicine
ScienceIsolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
6,890 Citations1989Qui‐Lim Choo, George Kuo +4 more
A random-primed complementary DNA library was constructed from plasma containing the uncharacterized non-A, non-B hepatitis agent and screened with serum from a patient diagnosed with NANBH, showing consistent with the agent being similar to the togaviridae or flaviviridae.
Statistical Methods in Cancer Research
6,727 Citations1980N. E. Breslow
ScienceAn Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
3,377 Citations1989George Kuo, Q L Choo +18 more
Assays of ten blood transfusions in the United States that resulted in chronic NANBH revealed that there was at least one positive blood donor in nine of these cases and that all ten recipients seroconverted during their illnesses.
New England Journal of MedicineDetection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1,684 Citations1989Harvey J. Alter, Robert H. Purcell +5 more
It is concluded that hepatitis C virus is the predominant agent of transfusion-associated non-A, non-B hepatitis and that screening of donors for anti-HCV could prevent the majority of cases of the disease.
The LancetHEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
900 Citations1989Rafael Esteban, L. Viladomiu +12 more
The frequency of hepatitis C virus infection in Spain was assessed by means of a recombinant-based immunoassay for serum anti-HCV antibodies and only 8% of homosexual men infected with human immunodeficiency virus and 6% of female contacts of drug abusers were positive.
The LancetPREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS
739 Citations1989Jordi Bruix, Xavier Calvet +10 more
The results indicate that HCV infection may have a role in the pathogenesis of hepatocellular carcinoma, even in patients with chronic liver disease apparently related to other agents such as alcohol, and that this recently identified hepatitis virus may be found in a large proportion of patients with cryptogenic cirrhosis.
The LancetPREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
668 Citations1989Massimo Colombo, Q L Choo +6 more
Data indicate that, in Italy, HCV is an important factor associated with hepatocellular carcinoma and non-A, non-B chronic hepatitis.
PubMedEstimates of the worldwide frequency of twelve major cancers.
436 Citations1984D M Parkin, Jan Stjernswärd +1 more
By examination of incidence, mortality, and relative frequency data, an estimate has been made of the number of cancer cases in 12 common sites and of all cancers that occurred in 1975 and in the 24 areas of the world for which the UN publishes population data.
The LancetHepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?
427 Citations1990Ian G. McFarlane
The findings suggest that serum from AI-CAH patients may contain a component that gives false-positive results in the assay, and this component may be associated with immunosuppressant therapy.
PubMed[Epidemiology of hepatocellular carcinoma].
328 Citations1992Ricca Rosellini S, F Miglio
In addition to HBV infection, cirrhosis, aflatoxins, alcohol, tobacco smoking and oral contraceptives have been evaluated as risk factors for HCC; the importance of the contribution of these risk factors to the development of HCC and the perspectives for prevention in different geographical areas will be discussed.
The LancetHepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma
255 Citations1990Michael C. Kew, Michael Houghton +2 more
In southern Africa, HCV is associated with hepatocellular carcinoma but HBV is present in a higher proportion of patients, and the average age is higher and women and urban dwellers are more likely to be infected.
JNCI Journal of the National Cancer InstitutePrevalence of Hepatitis B and C Viral Markers in Black and White Patients With Hepatocellular Carcinoma in the United States
179 Citations1990Mimi C. Yu, Myron J. Tong +4 more
The results indicate that the presence of anti-HCV was a significant risk factor for hepatocellular carcinoma, and a synergistic effect on risk was observed when both hepatitis B and C viral markers were present in peripheral blood.
Annals of Internal MedicinePrimary Hepatocellular Carcinoma After Chronic Non-A, Non-B Post-Transfusion Hepatitis
117 Citations1984John H. Gilliam, KIM R. GEISINGER +1 more
Excerpt Epidemiologic evidence of an association between hepatitis B virus and hepatocellular carcinoma is strong, but evidence of a similar association between non-A, non-B hepatitis virus infecting animals is weak.
The LancetHEPATITIS B AND PRIMARY HEPATOCELLULAR CARCINOMA IN A EUROPEAN POPULATION
115 Citations1978D. Trichopoulos, Robert J. Gerety +5 more
The relationship between active hepatitis B and P.H.C.V. seen in African and Asian populations is now seen in a European Caucasian population with different racial, environmental, and dietary circumstances.
International Journal of CancerHepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma
115 Citations1987Dimitrios Trichopoulos, Αναστασία Τζώνου +6 more
There is a statistically significant and dose‐dependent association between tobacco smoking and HBsAg‐negative HCC, and HBV may affect the development of HCC through at least two different and potentially multiplicative mechanisms (DNA integration and liver regeneration).
Cancer Chemotherapy and PharmacologyA large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking
63 Citations1989Takeshi Hirayama
A large-scale cohort study in Japan on life styles and primary liver cancer in men revealed a close association with cigarette smoking comparable to that for lung cancer, the relative risk for those smoking 1–29 and 30 or more cigarettes daily being 3.r.
Serodiagnosis and Immunotherapy in Infectious DiseaseImmunoglobulin G avidity in Epstein-Barr virus infections in organ transplant recipients
22 Citations1989J. Gray, T. G. Wreghitt
Low-avidity IgG to EBV VCA was present in serum after primary infection with EBV but absent during the reactivation of a past infection.
PubMedDoes non-A, non-B hepatitis cause hepatocellular carcinoma?
9 Citations1989Purcell Rh
The mechanism by which HBV infection leads to hepatocellular carcinoma is not as well defined as one would wish, but another mechanism more closely related to chronic cell death and regeneration resulting from chronic hepatitis is probably also important and hepadnaviral hepatocarcinogenesis may be multifaceted.